Hays | Global Pharma and Life Sciences Report | Access your copy
Tackling talent challenges in the Life Sciences industry
Transformation continues. What began as a pandemic-era surge in investment has evolved into a new phase of sustained change, driven by digital R&D, advanced therapies, and a refigured global value chain.
While organisations like yours look to scale and embrace new innovations, there are added pressures around compliance on top of greater agility demands and changing customer expectations. And all of this is reshaping the sector’s talent landscape in fundamental ways.
Workforce models are being tested. Skills gaps are widening and competition for specialised talent is intensifying, be it for RNA scientists, regulatory strategists, AI engineers, manufacturing specialists, or more.
As complexity grows, so does the need for a more agile, strategic approach to talent.
This new report, developed by Everest Group in partnership with Hays, offers a clear view of the evolving talent market across Pharma and Life Sciences. It breaks down the challenges and opportunities facing different industry segments and provides practical insights to help you handle the challenges and build future-ready teams.
- A global overview of the Life Sciences talent market today.
- Hiring trends across Pharmaceuticals, Biotech, Medical Devices, Contract Services and Digital Health.
- Country-level insights to help navigate local talent dynamics.
- Strategies to close skills gaps and adapt workforce models for long-term success.
*This report is a streamlined snapshot of the full insights. To explore the complete findings, please get in touch.


Explore the insights
Read our short report to explore how you can advance your talent strategy for continued success in Life Sciences today.

Review 2024 trends
Take a look at the previous edition to understand how talent trends have shifted over time.

Let's start a conversation
Get in touch to access more in-depth insights and realise new opportunities for your organisation.